These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 1492040

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Management of the chronic renal failure patient receiving epoetin alfa for the treatment of anemia.
    Binkley LS.
    Transplant Proc; 1991 Apr; 23(2):1831-2. PubMed ID: 2053169
    [No Abstract] [Full Text] [Related]

  • 9. The anemia of chronic renal failure: pathophysiology and effects of recombinant erythropoietin.
    Eschbach JW, Haley NR, Adamson JW.
    Contrib Nephrol; 1990 Apr; 78():24-36; discussion 37. PubMed ID: 2225841
    [No Abstract] [Full Text] [Related]

  • 10. [The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis].
    von Appen K, Klinkmann H.
    Urol Nefrol (Mosk); 1990 Apr; (6):69-70. PubMed ID: 2089771
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Peritonitis in children undergoing dialysis. 10 years experience.
    Levy M, Balfe JW, Geary DF, Fryer-Keene SP, Bannatyne RM.
    Child Nephrol Urol; 1990 Apr; 9(5):253-8. PubMed ID: 3271590
    [Abstract] [Full Text] [Related]

  • 16. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].
    Jalil R, Vaccarezza A, Jara A, Lira P, Vial S, Serrano V.
    Rev Med Chil; 1990 Jun; 118(6):629-34. PubMed ID: 1775783
    [Abstract] [Full Text] [Related]

  • 17. [Prophylaxis and management of catheter-associated infections in peritoneal dialysis patients: recent studies and guidelines].
    Kopriva-Altfahrt G, Moser E, Prokschi A, Kraus B, Kovarik J.
    Wien Klin Wochenschr; 2005 Jun; 117 Suppl 6():73-82. PubMed ID: 16437337
    [Abstract] [Full Text] [Related]

  • 18. Home intermittent peritoneal dialysis.
    Goldberg M, Baugham KB, Wombolt DG.
    Proc Clin Dial Transplant Forum; 1980 Jun; 10():224-6. PubMed ID: 7050984
    [No Abstract] [Full Text] [Related]

  • 19. Effect of recombinant human erythropoietin on soluble interleukin 2 receptor (SIL-2R) levels in haemodialysis patients.
    Altun B, Erdem Y, Haznedaroğlu I, Gürsoy M, Yasavul U, Turgan C, Cağlar S, Kirazli S.
    Nephrol Dial Transplant; 1995 Nov; 10(11):2164. PubMed ID: 8643199
    [No Abstract] [Full Text] [Related]

  • 20. Does correction of anemia with recombinant human erythropoietin accelerate the progression of renal insufficiency?
    Lim VS.
    Semin Nephrol; 1990 Mar; 10(2 Suppl 1):26-7. PubMed ID: 2356366
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.